One-Year Follow-Up after Endobronchial Valve Treatment in Patients with Emphysema without Collateral Ventilation Treated in the STELVIO Trial
Open Access
- 15 December 2016
- journal article
- research article
- Published by S. Karger AG in Respiration
- Vol. 93 (2) , 112-121
Abstract
Background: One-way endobronchial valve (EBV) treatment has shown safety and efficacy at 6 months after treatment in patients with severe emphysema and confirmed absence of interlobar collateral ventilation. Longer follow-up in this subgroup is not available. Objectives: To investigate the efficacy and safety of EBV treatment of the STELVIO cohort at a 1-year follow-up. Methods: Emphysema patients who have been treated with EBV in the STELVIO trial were invited for a voluntary 1-year follow-up visit. Both the original treatment group and the control group who crossed over to treatment have been included. Analyses are performed on the patients who attended the 1-year follow-up visit. Results: Sixty-four patients received EBV treatment. At 1 year, 40 patients (26 female; mean age 59 ± 8 years; FEV1 0.86 ± 0.29 L; RV 4.56 ± 1.00 L; 6MWD 367 ± 78 m; and SGRQ 56 ± 13 points) visited the hospital. Significant improvements (p < 0.001) were found for FEV1 (+17%, 95% CI, 11 to 24), RV (-687 mL, 95% CI, -918 to -456), 6MWD (+61 m, 95% CI, 42 to 80), and SGRQ (-11 points, 95% CI, −17 to −6). Two patients died: 1 after 58 days due to progressive respiratory failure and 1 after 338 days of follow-up due to a myocardial infarction. Seventeen percent of the patients underwent valve replacement and 22% of the initially treated patients had permanent valve removal. In 22% of the patients, pneumothoraces occurred before 6 months, and none occurred between 6 and 12 months. Conclusions: EBV treatment results in clinically relevant benefits at 1 year of follow-up. Maintenance bronchoscopies to achieve this are needed. This study supports the use of EBV treatment in carefully selected patients with severe emphysema without collateral ventilation.Keywords
This publication has 28 references indexed in Scilit:
- Endobronchial Valves for Emphysema without Interlobar Collateral VentilationNew England Journal of Medicine, 2015
- Target lobe volume reduction and COPD outcome measures after endobronchial valve therapyEuropean Respiratory Journal, 2013
- COPD Assessment Test –Rationale, Development, Validation and PerformanceCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2013
- Emphysema lung lobe volume reduction: effects on the ipsilateral and contralateral lobesEuropean Radiology, 2012
- The minimal important difference for residual volume in patients with severe emphysemaEuropean Respiratory Journal, 2012
- Efficacy predictors of lung volume reduction with Zephyr valves in a European cohortEuropean Respiratory Journal, 2012
- Long-term follow-up after bronchoscopic lung volume reduction in patients with emphysemaEuropean Respiratory Journal, 2011
- Atelectasis and survival after bronchoscopic lung volume reduction for COPDEuropean Respiratory Journal, 2010
- Minimal Clinically Important Differences in COPD Lung FunctionCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2005
- ATS Statement: Guidelines for the Six-Minute Walk TestAmerican Journal of Respiratory and Critical Care Medicine, 2002